157 related articles for article (PubMed ID: 11528550)
41. XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL.
Hundsdoerfer P; Dietrich I; Schmelz K; Eckert C; Henze G
Pediatr Blood Cancer; 2010 Aug; 55(2):260-6. PubMed ID: 20582956
[TBL] [Abstract][Full Text] [Related]
42. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
Leukemia; 2002 Aug; 16(8):1437-42. PubMed ID: 12145682
[TBL] [Abstract][Full Text] [Related]
43. Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.
Thyss A; Suciu S; Bertrand Y; Mazingue F; Robert A; Vilmer E; Mechinaud F; Benoit Y; Brock P; Ferster A; Lutz P; Boutard P; Marguerite G; Plouvier E; Michel G; Plantaz D; Munzer M; Rialland X; Chantraine JM; Norton L; Solbu G; Philippe N; Otten J
J Clin Oncol; 1997 May; 15(5):1824-30. PubMed ID: 9164191
[TBL] [Abstract][Full Text] [Related]
44. Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
Rhein P; Scheid S; Ratei R; Hagemeier C; Seeger K; Kirschner-Schwabe R; Moericke A; Schrappe M; Spang R; Ludwig WD; Karawajew L
Leukemia; 2007 May; 21(5):897-905. PubMed ID: 17330098
[TBL] [Abstract][Full Text] [Related]
45. von Willebrand factor and thrombin activation in children with newly diagnosed acute lymphoblastic leukemia: an impact of peripheral blasts.
Athale U; Moghrabi A; Nayiager T; Delva YL; Thabane L; Chan AK
Pediatr Blood Cancer; 2010 Jul; 54(7):963-9. PubMed ID: 20405515
[TBL] [Abstract][Full Text] [Related]
46. P-glycoprotein activity predicts outcome in childhood acute lymphoblastic leukemia.
Brozek J; Bryl E; Płoszyńska A; Balcerska A; Witkowski JM
J Pediatr Hematol Oncol; 2009 Jul; 31(7):493-9. PubMed ID: 19564743
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
Reiter A; Schrappe M; Ludwig WD; Hiddemann W; Sauter S; Henze G; Zimmermann M; Lampert F; Havers W; Niethammer D
Blood; 1994 Nov; 84(9):3122-33. PubMed ID: 7949185
[TBL] [Abstract][Full Text] [Related]
48. Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Lauten M; Schrauder A; Kardinal C; Harbott J; Welte K; Schlegelberger B; Schrappe M; von Neuhoff N
Leukemia; 2006 May; 20(5):820-6. PubMed ID: 16541142
[TBL] [Abstract][Full Text] [Related]
49. Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Griffin TC; Shuster JJ; Buchanan GR; Murphy SB; Camitta BM; Amylon MD
Leukemia; 2000 May; 14(5):792-5. PubMed ID: 10803508
[TBL] [Abstract][Full Text] [Related]
50. Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.
Schwartz CL; Thompson EB; Gelber RD; Young ML; Chilton D; Cohen HJ; Sallan SE
J Clin Oncol; 2001 Feb; 19(4):1040-6. PubMed ID: 11181667
[TBL] [Abstract][Full Text] [Related]
51. The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia.
Gruhn B; Naumann T; Gruner D; Walther M; Wittig S; Becker S; Beck JF; Sonnemann J
Leuk Res; 2013 Oct; 37(10):1200-7. PubMed ID: 23948281
[TBL] [Abstract][Full Text] [Related]
52. Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia.
Gasic V; Zukic B; Stankovic B; Janic D; Dokmanovic L; Lazic J; Krstovski N; Dolzan V; Jazbec J; Pavlovic S; Kotur N
Radiol Oncol; 2018 Sep; 52(3):296-306. PubMed ID: 30210047
[TBL] [Abstract][Full Text] [Related]
53. Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Gaynon PS; Bleyer WA; Steinherz PG; Finklestein JZ; Littman P; Miller DR; Reaman G; Sather H; Hammond GD
Med Pediatr Oncol; 1990; 18(4):273-9. PubMed ID: 2355886
[TBL] [Abstract][Full Text] [Related]
54. High expression of Midkine (MK) indicates poor prognosis in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Cheng YP; Luo ZB; Zhang JY; Li SS; Xu XJ; Tang YM
Hematology; 2016 Mar; 21(2):69-77. PubMed ID: 26352402
[TBL] [Abstract][Full Text] [Related]
55. Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia.
Ociepa T; Maloney E; Kamieńska E; Wysocki M; Kurylak A; Matysiak M; Urasiński T; Urasińska E; Domagała W
Pol J Pathol; 2010; 61(4):199-205. PubMed ID: 21290342
[TBL] [Abstract][Full Text] [Related]
56. Utility of the Technicon H-1 flags in the detection of peripheral blood blast cells of paediatric acute leukaemia patients.
Fernández-Castro M; Viloria A
Acta Haematol; 1995; 93(1):9-12. PubMed ID: 7725855
[TBL] [Abstract][Full Text] [Related]
57. Clinical features and outcome of pediatric acute lymphoblastic leukemia with low peripheral blood blast cell count at diagnosis.
Dai Q; Zhang G; Yang H; Wang Y; Ye L; Peng L; Shi R; Guo S; He J; Jiang Y
Medicine (Baltimore); 2021 Jan; 100(4):e24518. PubMed ID: 33530278
[TBL] [Abstract][Full Text] [Related]
58. Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Childrens Cancer Group study.
Tubergen DG; Cullen JW; Boyett JM; Gilchrist GS; O'Brien RT; Coccia PF; Waskerwitz MJ
J Clin Oncol; 1994 Feb; 12(2):273-8. PubMed ID: 8113836
[TBL] [Abstract][Full Text] [Related]
59. Glutathione in childhood acute leukaemias.
Kearns P; Pieters R; Rottier MM; Veerman AJ; Schmiegalow K; Pearson AD; Hall AG
Adv Exp Med Biol; 1999; 457():211-6. PubMed ID: 10500796
[TBL] [Abstract][Full Text] [Related]
60. Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival.
Elliott MA; Litzow MR; Letendre LL; Wolf RC; Hanson CA; Tefferi A; Tallman MS
Blood; 2007 Dec; 110(13):4172-4. PubMed ID: 17909077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
